Moderate to vigorous physical activity participation associated with better quality of life among breast and colorectal cancer survivors in Korea.

Abstract:

BACKGROUND:To investigate the association between physical activity (PA) and quality of life (QoL) among breast and colorectal cancer survivors in Korea. METHODS:A total of 224 cancer survivors (151 breast and 73 colorectal cancers) who completed treatments were recruited. We measured PA level with Godin Leisure-Time Exercise Questionnaire and QoL with European Organization for Research and Treatment of Cancer (EORTC) QLQ C-30. RESULTS:Moderate to vigorous PA was significantly correlated with global QoL (r = .311, p < 0.01), physical functioning (r = .231, p < 0.01), fatigue (r = -.176, p < 0.05), pain (r = -.154, p < 0.05), and dyspnea (r = -.221, p < 0.01) while no correlation was found between light PA and QoL after controlling for potential confounders. When we further divided our participants into four groups by total PA level, we found a strong linear dose-response relationship between higher total PA and better QoL outcomes (p < .001). Compared with participants in the lowest quartile, those in the highest quartile had significantly better score in global QoL (65.8 ± 2.7 vs. 77.6 ± 2.8, p = 0.003), physical functioning (67.2 ± 2.3 vs. 85.3 ± 2.4, p = 0.007), fatigue (35.9 ± 3.2 vs. 23.6 ± 3.2, p = 0.008), pain (22.7 ± 3.3 vs. 13.0 ± 3.4, p = 0.046), and dyspnea (13.7 ± 2.5 vs. 5.9 ± 2.6, p = 0.034). CONCLUSIONS:Higher PA level was associated with better QoL among breast and colorectal cancer survivors in Korea. Increasing PA levels should be included as one of important strategies to improve QoL in cancer survivors.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Park JH,Lee DH,Kim SI,Kim NK,Jeon JY

doi

10.1186/s12885-020-06819-z

subject

Has Abstract

pub_date

2020-05-01 00:00:00

pages

365

issue

1

issn

1471-2407

pii

10.1186/s12885-020-06819-z

journal_volume

20

pub_type

杂志文章
  • Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients.

    abstract:BACKGROUND:This study aimed to investigate the clinical utility of serum and histological MMP-9 detection during neoadjuvant chemotherapy (NAC) for triple-negative breast cancer (TNBC). METHODS:A total of 303 TNBC patients who underwent weekly paclitaxel plus carboplatin treatments followed by surgical resection were ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4822-7

    authors: Wang RX,Chen S,Huang L,Shao ZM

    更新日期:2018-09-21 00:00:00

  • Combination of albendazole and 2-methoxyestradiol significantly improves the survival of HCT-116 tumor-bearing nude mice.

    abstract:BACKGROUND:Albendazole (ABZ) is a microtubule-targeting anthelmintic with a remarkable activity against a variety of human cancer cells. In this study, we examined if the antitumor activity of ABZ could be enhanced by its combination with other microtubule-binding agents. METHODS:The interactions between ABZ and micro...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-86

    authors: Ehteda A,Galettis P,Pillai K,Morris DL

    更新日期:2013-02-23 00:00:00

  • Tumor classification and biomarker discovery based on the 5'isomiR expression level.

    abstract:BACKGROUND:The miRNA isoforms (isomiRs) have been suggested to regulate the same pathways as the canonical miRNA and play an important biological role in miRNA-mediated gene regulation. Recently, a study has demonstrated that the presence or absence of all isomiRs could efficiently discriminate amongst 32 TCGA cancer t...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5340-y

    authors: Wang S,Zheng Z,Chen P,Wu M

    更新日期:2019-02-07 00:00:00

  • A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America.

    abstract:BACKGROUND:Genetic counselling and testing for Lynch syndrome (LS) have recently been introduced in several Latin America countries. We aimed to characterize the clinical, molecular and mismatch repair (MMR) variants spectrum of patients with suspected LS in Latin America. METHODS:Eleven LS hereditary cancer registrie...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3599-4

    authors: Rossi BM,Palmero EI,López-Kostner F,Sarroca C,Vaccaro CA,Spirandelli F,Ashton-Prolla P,Rodriguez Y,de Campos Reis Galvão H,Reis RM,Escremim de Paula A,Capochin Romagnolo LG,Alvarez K,Della Valle A,Neffa F,Kalfayan PG,Spir

    更新日期:2017-09-05 00:00:00

  • Comparison of different therapeutic strategies for complete hydatidiform mole in women at least 40 years old: a retrospective cohort study.

    abstract:BACKGROUND:There are three main therapeutic strategies, namely expectant management (dilation and curettage only), prophylactic chemotherapy and prophylactic total hysterectomy for treating older women with complete hydatidiform mole (CHM). However, the scientific community has so far, not unanimously accepted the abov...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3749-8

    authors: Zhao P,Chen Q,Lu W

    更新日期:2017-11-09 00:00:00

  • Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis.

    abstract:BACKGROUND:Clinical trials where cancer patients were treated with protease inhibitors have suggested that the serine protease, prostasin, may act as a tumour suppressor. Prostasin is proteolytically activated by the serine protease, matriptase, which has a very high oncogenic potential. Prostasin is inhibited by prote...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-201

    authors: Selzer-Plon J,Bornholdt J,Friis S,Bisgaard HC,Lothe IM,Tveit KM,Kure EH,Vogel U,Vogel LK

    更新日期:2009-06-25 00:00:00

  • Suppression of local invasion of ameloblastoma by inhibition of matrix metalloproteinase-2 in vitro.

    abstract:BACKGROUND:Ameloblastomas are odontogenic neoplasms characterized by local invasiveness. This study was conducted to address the role of matrix metalloproteinase-2 (MMP-2) in the invasiveness of ameloblastomas. METHODS:Plasmids containing either MMP-2 siRNA or tissue inhibitor of metalloproteinase-2 (TIMP-2) cDNA were...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-182

    authors: Wang A,Zhang B,Huang H,Zhang L,Zeng D,Tao Q,Wang J,Pan C

    更新日期:2008-06-30 00:00:00

  • Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells.

    abstract:BACKGROUND:Acute myeloid leukemia (AML) is a heterogenic lethal disorder characterized by the accumulation of abnormal myeloid progenitor cells in the bone marrow which results in hematopoietic failure. Despite various efforts in detection and treatment, many patients with AML die of this cancer. That is why it is impo...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06903-4

    authors: Gil-Kulik P,Dudzińska E,Radzikowska-Büchner E,Wawer J,Jojczuk M,Nogalski A,Wawer GA,Feldo M,Kocki W,Cioch M,Bogucka-Kocka A,Rahnama M,Kocki J

    更新日期:2020-05-18 00:00:00

  • ATF-3/miR-590/GOLPH3 signaling pathway regulates proliferation of breast cancer.

    abstract:BACKGROUND:Breast cancer is one of the leading causes of death in women worldwide. Fast growth is the important character of breast cancer, which makes sure the subsequent metastasize and invasion breast cancer. Golgi related genes GOLPH3 has been reported to regulate many kinds of cancers proliferation. However, its u...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4031-4

    authors: Song Q,Chen Q,Wang Q,Yang L,Lv D,Jin G,Liu J,Li B,Fei X

    更新日期:2018-03-09 00:00:00

  • Telomere length differences between colorectal polyp subtypes: a colonoscopy-based case-control study.

    abstract:BACKGROUND:Short telomeres have been associated with increased risk of many cancers, particularly cancers of the gastrointestinal tract including esophagus and stomach. However, the association between telomere length (TL) and colorectal cancer and its precursors, colorectal polyps, is not clear. METHODS:We investigat...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4426-2

    authors: Hardikar S,Burnett-Hartman AN,Phipps AI,Upton MP,Zhu LC,Newcomb PA

    更新日期:2018-05-02 00:00:00

  • Inhibitory effects of prostaglandin E2 on collagen synthesis and cell proliferation in human stellate cells from pancreatic head adenocarcinoma.

    abstract:BACKGROUND:Several studies have described an increased cyclooxygenase-2 (COX-2) expression in pancreatic cancer, but the role of COX-2 in tumour development and progression is not clear. The aim of the present study was to examine expression of COX-2 in cancer cells and stromal cells in pancreatic cancer specimens, and...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-413

    authors: Pomianowska E,Sandnes D,Grzyb K,Schjølberg AR,Aasrum M,Tveteraas IH,Tjomsland V,Christoffersen T,Gladhaug IP

    更新日期:2014-06-09 00:00:00

  • Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells.

    abstract:BACKGROUND:c-Met signaling has been implicated in oncogenesis especially in cells with c-met gene amplification. Since 20 % of gastric cancer patients show high level of c-Met expression, c-Met has been identified as a good candidate for targeted therapy in gastric cancer. Herein, we report our newly synthesized c-Met ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2058-y

    authors: Park CH,Cho SY,Ha JD,Jung H,Kim HR,Lee CO,Jang IY,Chae CH,Lee HK,Choi SU

    更新日期:2016-01-22 00:00:00

  • Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer.

    abstract:BACKGROUND:Venous thromboembolic events (VTE) are common in cancer patients and associated with higher mortality. In vivo thrombosis and anticoagulation might be involved in tumor growth and progression. We studied the association of warfarin and other anticoagulant use as antithrombotic medication and prostate cancer ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3579-8

    authors: Kinnunen PTT,Murtola TJ,Talala K,Taari K,Tammela TLJ,Auvinen A

    更新日期:2017-08-29 00:00:00

  • Elevated levels of plasma D-dimer predict a worse outcome in patients with nasopharyngeal carcinoma.

    abstract:BACKGROUND:Hemostatic alterations occur during the development of cancer. Plasma D-dimer is a hypercoagulability and fibrinolytic system marker that is increased in patients with various solid tumours. The aim of this study was to evaluate the hemostatic status of nasopharyngeal carcinoma (NPC) patients by assessing pl...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-583

    authors: Chen WH,Tang LQ,Wang FW,Li CP,Tian XP,Huang XX,Mai SJ,Liao YJ,Deng HX,Chen QY,Liu H,Zhang L,Guo SS,Liu LT,Yan SM,Li CF,Zhang JP,Liu Q,Liu XW,Liu LZ,Mai HQ,Zeng MS,Xie D

    更新日期:2014-08-10 00:00:00

  • Metastatic breast cancer patient perceptions of somatic tumor genomic testing.

    abstract:BACKGROUND:To assess metastatic breast cancer (MBC) patient psychological factors, perceptions, and comprehension of tumor genomic testing. METHODS:In a prospective, single institution, single-arm trial, patients with MBC underwent next-generation sequencing at study entry with sequencing results released at progressi...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06905-2

    authors: Adams EJ,Asad S,Reinbolt R,Collier KA,Abdel-Rasoul M,Gillespie S,Chen JL,Cherian MA,Noonan AM,Sardesai S,VanDeusen J,Wesolowski R,Williams N,Shapiro CL,Macrae ER,Pilarski R,Toland AE,Senter L,Ramaswamy B,Lee CN,Lu

    更新日期:2020-05-06 00:00:00

  • The prognostic effect of perineural invasion in esophageal squamous cell carcinoma.

    abstract:BACKGROUND:Perineural invasion (PNI) is correlated with adverse survival in several malignancies, but its significance in esophageal squamous cell carcinoma (ESCC) remains to be clearly defined. The objective of this study was to determine the association between PNI status and clinical outcomes. METHODS:We retrospect...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-313

    authors: Chen JW,Xie JD,Ling YH,Li P,Yan SM,Xi SY,Luo RZ,Yun JP,Xie D,Cai MY

    更新日期:2014-05-05 00:00:00

  • The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma.

    abstract:BACKGROUND:BCOR acts as a corepressor of BCL6, a potent oncogenic protein in cancers of the lymphoid lineage. We have found the recurrent somatic mutation of BCOR occurred in mature T-cell lymphoma (TCL). The role of BCOR mutation in lymphoid malignancies is unknown. METHODS:Lymphoma patient samples were analyzed to i...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-021-07806-8

    authors: Kang JH,Lee SH,Lee J,Choi M,Cho J,Kim SJ,Kim WS,Ko YH,Yoo HY

    更新日期:2021-01-19 00:00:00

  • The spectrum of resistance in SR/CR mice: the critical role of chemoattraction in the cancer/leukocyte interaction.

    abstract:BACKGROUND:Spontaneous regression/complete resistance (SR/CR) mice are a unique colony of mice that possess an inheritable, natural cancer resistance mediated primarily by innate cellular immunity. This resistance is effective against sarcoma 180 (S180) at exceptionally high doses and these mice remain healthy. METHOD...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-179

    authors: Riedlinger G,Adams J,Stehle JR Jr,Blanks MJ,Sanders AM,Hicks AM,Willingham MC,Cui Z

    更新日期:2010-05-03 00:00:00

  • The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients.

    abstract:BACKGROUND:CD133 (prominin-1) is widely believed to be a cancer stem cell marker in various solid tumor types, and CD133 has been correlated with tumor-initiating capacity. Recently, the nuclear location of CD133 expression in tumors has been discussed, but hepatocellular carcinoma (HCC) has not been included in these ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3460-9

    authors: Chen YL,Lin PY,Ming YZ,Huang WC,Chen RF,Chen PM,Chu PY

    更新日期:2017-07-07 00:00:00

  • Exercise efficacy and prescription during treatment for pancreatic ductal adenocarcinoma: a systematic review.

    abstract:BACKGROUND:Surgical resection remains the only curative treatment for pancreatic cancer and is associated with significant post-operative morbidity and mortality. Patients eligible for surgery, increasingly receive neo-adjuvant therapy before surgery or adjuvant therapy afterward, inherently exposing them to toxicity. ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07733-0

    authors: O'Connor D,Brown M,Eatock M,Turkington RC,Prue G

    更新日期:2021-01-09 00:00:00

  • Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.

    abstract:BACKGROUND:Embryonic Liver Fodrin (ELF) is an adaptor protein of transforming growth factor (TGF-β) signaling cascade. Disruption of ELF results in mislocalization of Smad3 and Smad4, leading to compromised TGF-β signaling. c-Myc is an important oncogenic transcription factor, and the disruption of TGF-β signaling prom...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4379-5

    authors: Ji F,Zhang ZH,Zhang Y,Shen SL,Cao QH,Zhang LJ,Li SQ,Peng BG,Liang LJ,Hua YP

    更新日期:2018-04-24 00:00:00

  • The release of tryptase from mast cells promote tumor cell metastasis via exosomes.

    abstract:BACKGROUND:Cancer cells release exosomes and can be taken up by mast cells (MCs), but the potential functional effects of MCs on tumor metastasis remain unknown. METHOD:Exosomes were isolated from the lung adenocarcinoma cell line A549, and the uptake of PKH26-labeled exosomes by bone marrow MCs was examined via flow ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6203-2

    authors: Xiao H,He M,Xie G,Liu Y,Zhao Y,Ye X,Li X,Zhang M

    更新日期:2019-10-29 00:00:00

  • Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis.

    abstract:BACKGROUND:Magnetic resonance imaging (MRI) may guide breast cancer surgery by measuring residual tumor size post-neoadjuvant chemotherapy (NAC). Accurate measurement may avoid overly radical surgery or reduce the need for repeat surgery. This individual patient data (IPD) meta-analysis examines MRI's agreement with pa...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-015-1664-4

    authors: Marinovich ML,Macaskill P,Irwig L,Sardanelli F,Mamounas E,von Minckwitz G,Guarneri V,Partridge SC,Wright FC,Choi JH,Bhattacharyya M,Martincich L,Yeh E,Londero V,Houssami N

    更新日期:2015-10-08 00:00:00

  • Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib.

    abstract:BACKGROUND:Tyrosine kinase inhibitors (TKIs) are currently approved for the treatment of metastatic renal cell carcinoma (mRCC). The cardiotoxic effects of sorafenib and sunitinib may cause hypertension, left ventricular ejection fraction (LVEF) dysfunction and/or congestive heart failure (CHF), and arterial thrombo-em...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-231

    authors: Pantaleo MA,Mandrioli A,Saponara M,Nannini M,Erente G,Lolli C,Biasco G

    更新日期:2012-06-11 00:00:00

  • Vascular disruptive agent OXi4503 and anti-angiogenic agent Sunitinib combination treatment prolong survival of mice with CRC liver metastasis.

    abstract:BACKGROUND:Preclinical research indicate that vascular disrupting agent (VDA) treatment induces extensive tumor death but also a systemic mobilization of bone marrow derived cells including endothelial progenitor cells (EPC) leading to revascularization and renewed growth within the residual tumor. This study investiga...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2568-7

    authors: Nguyen L,Fifis T,Christophi C

    更新日期:2016-07-26 00:00:00

  • Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups.

    abstract:BACKGROUND:PRDM5 is an epigenetic regulator that has been recognized as an important tumour suppressor gene. Silencing of PRDM5 by promoter hypermethylation has been demonstrated in several cancer types and PRDM5 loss results in upregulation of the Wnt pathway and increased cellular proliferation. PRDM5 has not been ex...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1011-9

    authors: Bond CE,Bettington ML,Pearson SA,McKeone DM,Leggett BA,Whitehall VL

    更新日期:2015-01-23 00:00:00

  • Correction to: A systematic comparison of copy number alterations in four types of female cancer.

    abstract::After publication of the original article [1] the authors found that the article contained an incorrect version of Fig. 4. This does not affect the results and conclusions of the article. ...

    journal_title:BMC cancer

    pub_type: 杂志文章,已发布勘误

    doi:10.1186/s12885-017-3766-7

    authors: Kaveh F,Baumbusch LO,Nebdal D,Børresen-Dale AL,Lingjærde OC,Edvardsen H,Kristensen VN,Solvang HK

    更新日期:2018-01-16 00:00:00

  • Lutetium oxodotreotide (177Lu-Dotatate) for the treatment of unresectable or metastatic progressive gastroenteropancreatic neuroendocrine tumors: a cost-effectiveness analysis for Scotland.

    abstract:BACKGROUND:Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) represent a heterogenous group of tumors. Findings from the phase III NETTER-1 trial showed that treatment of unresectable/metastatic progressive gastrointestinal (GI) NETs with 177Lu-Dotatate resulted in a significant improvement in progression-free su...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07710-7

    authors: Smith-Palmer J,Leeuwenkamp OR,Virk J,Reed N

    更新日期:2021-01-05 00:00:00

  • Assessment of cancers' diagnostic stage in a Deaf community - survey about 4363 Deaf patients recorded in French units.

    abstract:BACKGROUND:Deaf people represent 0.1% of the French population and their access to public health campaigns is limited due to their frequent illiteracy and the infrequent use of sign language in campaigns. There is also a lack of general health knowledge in spite of the existence of French Deaf Care Units (UASS). The ai...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3972-3

    authors: Druel V,Hayet H,Esman L,Clavel M,Rougé Bugat ME

    更新日期:2018-01-23 00:00:00

  • Adherence to quality breast cancer survivorship care in four Canadian provinces: a CanIMPACT retrospective cohort study.

    abstract:BACKGROUND:In order to maximize later health, there are established components and guidelines for quality follow-up care of breast cancer survivors. However, adherence to quality follow-up in Canada may not be optimal, and may vary by province. We determined and compared the proportion of patients in each province who ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5882-z

    authors: McBride ML,Groome PA,Decker K,Kendell C,Jiang L,Whitehead M,Li D,Grunfeld E,CanIMPACT Team.

    更新日期:2019-07-04 00:00:00